The Necessity of Studying Antibiotic Duration in Acute Leukemia Patients With Pseudomonas aeruginosa Bloodstream Infection: A Response to Terada and Kanno

Xiaomeng Feng; Chenjing Qian; Yuping Fan; Jia Li; Jieru Wang; Qingsong Lin; Erlie Jiang; Yingchang Mi; Lugui Qiu; Zhijian Xiao; Jianxiang Wang; Mei Hong; Sizhou Feng

doi:10.1093/cid/ciae013

The Necessity of Studying Antibiotic Duration in Acute Leukemia Patients With Pseudomonas aeruginosa Bloodstream Infection: A Response to Terada and Kanno

Clin Infect Dis. 2024 Oct 15;79(4):1119-1120. doi: 10.1093/cid/ciae013.

Authors

Xiaomeng Feng^{1

2}, Chenjing Qian³, Yuping Fan^{1

2}, Jia Li^{1

2}, Jieru Wang^{1

2}, Qingsong Lin^{1

2}, Erlie Jiang^{1

2}, Yingchang Mi^{1

2}, Lugui Qiu^{1

2}, Zhijian Xiao^{1

2}, Jianxiang Wang^{1

2}, Mei Hong³, Sizhou Feng^{1

2}

Affiliations

¹ State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
² Tianjin Institutes of Health Science, Tianjin, China.
³ Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

PMID: 38236155
DOI: 10.1093/cid/ciae013

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents* / therapeutic use
Bacteremia* / drug therapy
Bacteremia* / microbiology
Humans
Leukemia / complications
Leukemia / drug therapy
Pseudomonas Infections* / drug therapy
Pseudomonas Infections* / microbiology
Pseudomonas aeruginosa* / drug effects

Substances

Anti-Bacterial Agents